Sanoculis
Minimally Invasive Surgical Device for Glaucoma Treatment
StartupSanoculis is a Kiryat Ono-based startup in the Health Tech & Life Sciences sector, established in 2012. Minimally Invasive Surgical Device for Glaucoma Treatment. The company has raised a total of $18.5M across 3 funding rounds, currently at the C stage. Sanoculis was founded by Nir Israeli, Vadim Shmukler, Dr. Yoseph Glovinsky. Key investors include Bausch + Lomb, Eckuity, Infinity Group, among 6 total investors. The company has 1-10 employees. Core technologies: Sensing, Laser.
With $18.5M in total funding, Sanoculis is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageC
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQKiryat Ono
- DistrictCenter District
- Last Round$14M
- Bausch + Lomb
- Eckuity
- Infinity Group
6 investors total
Nir IsraeliCo-founder & CEO
Vadim ShmuklerCo-founder & CTO
Dr. Yoseph GlovinskyCo-founder & Medical Director
7 articles covered by sources including www.prnewswire.com,
eyewire.news,
www.globes.co.il,
www.healio.com.
What does Sanoculis do?
Sanoculis offers a new alternative surgical procedure for treating glaucoma. Its Minimally Invasive Micro Sclerostomy (MIMS) solution consists of a single-patient-use sterile tool and a multi-use external machine. In the course of the surgery, a sclero-corneal drainage channel is created to reduce intraocular pressure. MIMS is a microfluidic full-thickness procedure developed as an advanced laser sclerostomy. The technique uses a cutting and drilling device to reduce trauma to the surrounding tissue, minimizing scar tissue formation and allowing for a long-lasting filtering bleb. The MIMS channel ensures a controlled fluid flow with minor complications. In March 2017, Sanoculis was granted CE marking for its MIMS device and procedure.
How much funding has Sanoculis raised?
Sanoculis has raised $18.5M in total funding across 3 rounds. The company is currently at the C stage. Key investors include Bausch + Lomb, Eckuity, Infinity Group.
Who founded Sanoculis?
Sanoculis was founded in 2012 by Nir Israeli (Co-founder & CEO), Vadim Shmukler (Co-founder & CTO), Dr. Yoseph Glovinsky (Co-founder & Medical Director).
What sector is Sanoculis in?
Sanoculis operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Sensing, Laser. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Sanoculis located?
Sanoculis is based in Landau Street 10, Kiryat Ono, Israel, Center District.